James P. (Jim) Bradley provides advisory services to the healthcare industry, often serving as Executive Board Chairman of early to intermediate stage healthcare companies. He currently serves as a Director or Chairs the Boards of four such companies. In addition to his role at AdhereHealth, he sits on the Board of IcarioHealth. Based in the Twin Cities, the Company works to engage patients and reward healthy behavior on behalf of payers and at risk providers. Equiscript, based in Charleston, provides pharmacy management services to safety net providers and their patients. Mr. Bradley also Chairs the Board of VyncaCare, a supportive care provider which utilizes a hybrid approach to aid primary care physicians and specialists in their care for seriously ill patients that don’t have adequate access to care due to geographic location or various social or economic disadvantages.
He has Chaired the Board of a number of companies leading to very successful exits. Mr. Bradley Chaired the Board of AbilityNetwork, and helped facilitate significant revenue and EBITDA growth resulting in the company’s sale to Summit Partners, a prominent healthcare private equity firm based in Boston. During the same period, he chaired the Board of Wellpartner, a New York City based pharmacy administration services company sold to CVS. He served as the Board Chair of Apixio which was acquired by Centene Corporation. After the sale of Apixio, Mr. Bradley served as the Chair of Centene’s Healthcare Enterprises Board which oversaw many of Centene’s non-healthplan business units. And most recently, he Chaired the Board of Diameter Health through its exit to become part of Availity.
Other experience includes Chairing the Board of Trustees of the University of Minnesota Medical Center, and an assignment in which he served as Northrop Grumman’s Program Director of their Nationwide Health Information Network initiative sponsored by the Office of the National Coordinator for Health Information Technology of the US Department of Health and Human Services.
Mr. Bradley was the founding CEO of RxHub. RxHub (now Surescripts) is a healthcare technology company that has developed a nationwide electronic information exchange connecting prescribers, pharmacies and pharmacy benefit managers in order to permit the sharing of prescription, medication history, and benefit information between them.
Before RxHub, Mr. Bradley was a senior executive at McKesson Corporation, where he was responsible for technology strategy and reported to McKesson’s CEO. He was Chairman, CEO and founder of Abaton.com, Inc., a developer of web-based physician connectivity services and applications, which he sold to McKesson. Jim was also the Chief Information Officer of United HealthCare Corporation (UNH) and before that ran operations for the Northern half of the U.S for Aetna’s managed care plans as part of a joint venture with Voluntary Hospitals of America (VHA).
Mr. Bradley’s not-for-profit Board service includes the National Committee for Quality Assurance (NCQA) best known for accreditation of health plans and the developer of the Hedis measures that are used by CMS in rating the performance of health plans and at risk providers. Mr. Bradley chaired the NCQA Board from 2002 through 2005, and also was Chair of the Health Data Consortium (former sponsor of the Health DataPalooza annual conference) where he worked closely with the U.S. Health and Human Services staff to promote the use of data to improve healthcare. He has also served on the Board of Research Foundation of the American Society of Health System Pharmacy and was the Co-Chair of WEDI, the Workgroup on Electronic Data Interchange which was formed by then Secretary of HHS, Louis Sullivan, and which drafted the legislation which was to become known as HIPAA.
Mr. Bradley has lectured on health policy and health information technology topics at Washington University, Harvard, Wharton, the University of California, the University of Hawaii, the University of Illinois, and the University of Minnesota.
